Cargando…
Prescribing cannabis for harm reduction
Neuropathic pain affects between 5% and 10% of the US population and can be refractory to treatment. Opioids may be recommended as a second-line pharmacotherapy but have risks including overdose and death. Cannabis has been shown to be effective for treating nerve pain without the risk of fatal pois...
Autor principal: | Collen, Mark |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3295721/ https://www.ncbi.nlm.nih.gov/pubmed/22208773 http://dx.doi.org/10.1186/1477-7517-9-1 |
Ejemplares similares
-
Harm reduction-the cannabis paradox
por: Melamede, Robert
Publicado: (2005) -
The Rise and Rise of Medicinal Cannabis, What Now? Medicinal Cannabis Prescribing in Australia 2017–2022
por: Hallinan, Christine Mary, et al.
Publicado: (2022) -
The Olympics and harm reduction?
por: Kayser, Bengt, et al.
Publicado: (2012) -
Harm reduction in hospitals
por: Sharma, Malika, et al.
Publicado: (2017) -
Harm reduction in hospitals: is it time?
por: Rachlis, Beth S, et al.
Publicado: (2009)